SwePub
Sök i SwePub databas

  Utökad sökning

Träfflista för sökning "WFRF:(Axelsson Jesper) srt2:(2010-2014)"

Sökning: WFRF:(Axelsson Jesper) > (2010-2014)

  • Resultat 1-9 av 9
Sortera/gruppera träfflistan
   
NumreringReferensOmslagsbildHitta
1.
  • Axelsson, Jakob, et al. (författare)
  • Characteristics of software ecosystems for Federated Embedded Systems : A case study
  • 2014
  • Ingår i: Information and Software Technology. - : Elsevier BV. - 0950-5849 .- 1873-6025. ; 56:11, s. 1457-1475
  • Tidskriftsartikel (refereegranskat)abstract
    • Context Traditionally, Embedded Systems (ES) are tightly linked to physical products, and closed both for communication to the surrounding world and to additions or modifications by third parties. New technical solutions are however emerging that allow addition of plug-in software, as well as external communication for both software installation and data exchange. These mechanisms in combination will allow for the construction of Federated Embedded Systems (FES). Expected benefits include the possibility of third-party actors developing add-on functionality; a shorter time to market for new functions; and the ability to upgrade existing products in the field. This will however require not only new technical solutions, but also a transformation of the software ecosystems for ES. Objective This paper aims at providing an initial characterization of the mechanisms that need to be present to make a FES ecosystem successful. This includes identification of the actors, the possible business models, the effects on product development processes, methods and tools, as well as on the product architecture. Method The research was carried out as an explorative case study based on interviews with 15 senior staff members at 9 companies related to ES that represent different roles in a future ecosystem for FES. The interview data was analyzed and the findings were mapped according to the Business Model Canvas (BMC). Results The findings from the study describe the main characteristics of a FES ecosystem, and identify the challenges for future research and practice. Conclusions The case study indicates that new actors exist in the FES ecosystem compared to a traditional supply chain, and that their roles and relations are redefined. The business models include new revenue streams and services, but also create the need for trade-offs between, e.g., openness and dependability in the architecture, as well as new ways of working. © 2014 The Authors. Published by Elsevier B.V.
  •  
2.
  •  
3.
  • Axelsson, Malin, 1964-, et al. (författare)
  • Motivational foci and asthma medication tactics directed towards a functional day
  • 2011
  • Ingår i: BMC Public Health. - London : BioMed Central. - 1471-2458. ; 11, s. 809-
  • Tidskriftsartikel (refereegranskat)abstract
    • Background:There appears to be an obvious gap between a medical and patient adherence perspective.Deviating from a medication prescription could be regarded as fairly irrational, but with respect to patients' goals and/or concerns it could be seen as understandable. Thus, the aim was to elucidate adherence reasoning in relation to asthma medication.Methods:This was a qualitative study; data collection and analysis procedures were conducted according to Grounded Theory methodology. Eighteen persons, aged 22 with asthma and regular asthma medication treatment, were interviewed.Results:The emerged theoretical model illustrated that adherence to asthma medication was motivated by three foci, all directed towards a desired outcome in terms of a functional day as desired by the patient. Apromotive focus was associated with the ambition to achieve a positive asthma outcome by being adherent either to the received prescription or to a self-adjusted dosage. A preventive focuswas intended to ensure avoidance of a negative asthma outcome either by sticking to the prescription or by preventively overusing the medication. A permissive focus was associated with unstructured adherence behaviour in which medication intake was primarily triggered by asthma symptoms.Conclusions:As all participants had consciously adopted functioning medication tactics that directed themtowards the desired goal of a functional day. In an effort to bridge the gap between a patient- and a medical adherence perspective, patients need support in defining their desired functionality and guidance in developing a person-based medication tactic.
  •  
4.
  •  
5.
  •  
6.
  • Axelsson, Malin, 1964, et al. (författare)
  • Self-efficacy and adherence as mediating factors between personality traits and health-related quality of life.
  • 2013
  • Ingår i: Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation. - : Springer Science and Business Media LLC. - 1573-2649 .- 0962-9343. ; 22:3, s. 567-575
  • Tidskriftsartikel (refereegranskat)abstract
    • PURPOSE: Personality traits are rather stable dispositions in adulthood, while self-efficacy and adherence may be modified through targeted interventions. Health-related quality of life (HRQL) serves as a vital outcome measure. The present aim was to explore the function of self-efficacy and adherence as mediators for the influencing effect of personality traits on HRQL in people with chronic disease. METHODS: An epidemiological sample of 786 persons completed questionnaires on personality, general self-efficacy, adherence behaviour and HRQL. Data were statistically analysed using descriptive statistics, correlation analyses and path models. RESULTS: Self-efficacy mediated the effect of Extraversion and Conscientiousness on mental HRQL. Neuroticism had a direct effect on both physical and mental HRQL. Adherence partially mediated the effect of both Agreeableness and Conscientiousness on mental HRQL. CONCLUSIONS: The mental HRQL in people scoring low on Extraversion or low on Conscientiousness could be improved by strengthening general self-efficacy. Increasing adherence in people scoring low on Agreeableness or Conscientiousness could improve their mental HRQL, but the improvement was small and may be of lesser clinical relevance. These results argue for personalized interventions intended to positively affect health outcomes in people with chronic disease.
  •  
7.
  • Axelsson, Malin, 1964-, et al. (författare)
  • The influence of personality traits on reported adherence to medication in individuals with chronic disease : An Epidemiological study in West Sweden
  • 2011
  • Ingår i: PLOS ONE. - : Public Library of Science (PLoS). - 1932-6203. ; 6:3
  • Tidskriftsartikel (refereegranskat)abstract
    • Background: Limited research exists exploring the influence of personality on adherence behaviour. Since non-adherence is a major obstacle in treating prevalent chronic diseases the aim was to determine whether personality traits are related to reported adherence to medication in individuals with chronic disease. Methodology/Principal Findings: Individuals with chronic disease (n = 749) were identified in a random population sample of 5000 inhabitants aged 30-70 in two municipalities in West Sweden. Data on five personality traits, Neuroticism, Extraversion, Openness to experiences, Agreeableness, and Conscientiousness, and medication adherence behaviour was collected by questionnaires. Statistical analyses resulted in a negative relationship between Neuroticism and medication adherence (P<0.001), while both Agreeableness (P<0.001) and Conscientiousness (P<0.001) were positively related to adherence. At high levels of Conscientiousness, low adherence was related to higher scores in Neuroticism. At high levels of Agreeableness, low adherence was related to low scores in Conscientiousness and high scores in Openness to experiences. Conclusions: This study demonstrated that multiple personality traits are of significant importance for adherence behaviour in individuals with chronic disease. The findings suggest that several personality traits may interact in influencing adherence behaviour. Personality traits could putatively be used to focus efforts to educate and support patients with high risk of low medical adherence. © 2011 Axelsson et al.
  •  
8.
  • Papatheocharous, Efi, et al. (författare)
  • Issues and challenges in ecosystems for federated embedded systems
  • 2013
  • Ingår i: 1st ACM SIGSOFT/SIGPLAN International Workshop on Software Engineering for Systems-of-Systems, SESoS 2013 Proceedings. - New York, NY, USA : ACM. - 9781450320481 ; , s. 21-24
  • Konferensbidrag (refereegranskat)abstract
    • This paper discusses how Systems of Systems (SoS) can be constructed by linking together embedded computers in constituent systems to create complex but more flexible and adaptable systems. The approach of software system development is called Federated Embedded Systems (FES) and their revolved ecosystem of players is presented, aiming to ensure quality in engineering SoS. Ecosystems for Federated Embedded Systems (EcoFES) comprise a new area of research that scales component-based software development for embedded software into new dimensions. The proposed ecosystem dimension introduces an open, flexible and adaptable SoS architecture for improving the process of FES development. In the paper, we identify some architectural challenges and discuss the implications of scaling from a closed ecosystem to an open one, providing open collaboration and innovation in the context of FES.
  •  
9.
  • Xie, Haiyan, et al. (författare)
  • Drug quantification in turbid media by fluorescence imaging combined with light-absorption correction using white Monte Carlo simulations.
  • 2011
  • Ingår i: Journal of Biomedical Optics. - : SPIE-Intl Soc Optical Eng. - 1083-3668. ; 16:6
  • Tidskriftsartikel (refereegranskat)abstract
    • Accurate quantification of photosensitizers is in many cases a critical issue in photodynamic therapy. As a noninvasive and sensitive tool, fluorescence imaging has attracted particular interest for quantification in pre-clinical research. However, due to the absorption of excitation and emission light by turbid media, such as biological tissue, the detected fluorescence signal does not have a simple and unique dependence on the fluorophore concentration for different tissues, but depends in a complex way on other parameters as well. For this reason, little has been done on drug quantification in vivo by the fluorescence imaging technique. In this paper we present a novel approach to compensate for the light absorption in homogeneous turbid media both for the excitation and emission light, utilizing time-resolved fluorescence white Monte Carlo simulations combined with the Beer-Lambert law. This method shows that the corrected fluorescence intensity is almost proportional to the absolute fluorophore concentration. The results on controllable tissue phantoms and murine tissues are presented and show good correlations between the evaluated fluorescence intensities after the light-absorption correction and absolute fluorophore concentrations. These results suggest that the technique potentially provides the means to quantify the fluorophore concentration from fluorescence images.
  •  
Skapa referenser, mejla, bekava och länka
  • Resultat 1-9 av 9

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy